End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24â 45 years of age
Authors
Castellsague, XMunoz, N
Pitisuttithum, P
Ferris, Daron G.
Monsonego, J
Ault, Kevin A
Luna, J
Myers, E
Mallary, S
Bautista, O M
Bryan, J
Vuocolo, S
Haupt, Richard M
Saah, A
Issue Date
2011-06-28|
Metadata
Show full item recordAbstract
BackgroundMethods
Results
Conclusions
Citation
Br J Cancer. 2011 Jun 28; 105(1):28-37ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2011.185